175 related articles for article (PubMed ID: 38793012)
1. Healing of Periodontal Suprabony Defects following Treatment with Open Flap Debridement with or without Hyaluronic Acid (HA) Application.
Vela OC; Boariu M; Rusu D; Iorio-Siciliano V; Ramaglia L; Boia S; Radulescu V; Ilyes I; Stratul SI
Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38793012
[No Abstract] [Full Text] [Related]
2. Healing of periodontal suprabony defects following treatment with open flap debridement with or without an enamel matrix derivative: A randomized controlled clinical study.
Iorio-Siciliano V; Blasi A; Stratul SI; Ramaglia L; Octavia V; Salvi GE; Sculean A
Clin Oral Investig; 2021 Mar; 25(3):1019-1027. PubMed ID: 32562077
[TBL] [Abstract][Full Text] [Related]
3. Clinical and radiographic evaluation of 0.8% hyaluronic acid as an adjunct to open flap debridement in the treatment of periodontal intrabony defects: randomized controlled clinical trial.
Mamajiwala AS; Sethi KS; Raut CP; Karde PA; Mamajiwala BS
Clin Oral Investig; 2021 Sep; 25(9):5257-5271. PubMed ID: 33598778
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment of periodontal intrabony defects with calcium sulfate implant and barrier versus collagen barrier or open flap debridement alone: a 12-month randomized controlled clinical trial.
Paolantonio M; Perinetti G; Dolci M; Perfetti G; Tetè S; Sammartino G; Femminella B; Graziani F
J Periodontol; 2008 Oct; 79(10):1886-93. PubMed ID: 18834243
[TBL] [Abstract][Full Text] [Related]
5. The role of surgical flap design (minimally invasive flap vs. extended flap with papilla preservation) on the healing of intrabony defects treated with an enamel matrix derivative: a 12-month two-center randomized controlled clinical trial.
Windisch P; Iorio-Siciliano V; Palkovics D; Ramaglia L; Blasi A; Sculean A
Clin Oral Investig; 2022 Feb; 26(2):1811-1821. PubMed ID: 34491446
[TBL] [Abstract][Full Text] [Related]
6. Clinical and radiographic evaluation of low-speed platelet-rich fibrin (PRF) for the treatment of intra-osseous defects of stage-III periodontitis patients: a randomized controlled clinical trial.
Abdulrahman YA; Hosny MM; Elfana A; Fawzy El-Sayed KM
Clin Oral Investig; 2022 Nov; 26(11):6671-6680. PubMed ID: 35876893
[TBL] [Abstract][Full Text] [Related]
7. Gingival crevicular fluid vascular endothelial cell growth factor and platelet-derived growth factor-BB release profile following the use of perforated barrier membranes during treatment of intrabony defects: a randomized clinical trial.
Gamal AY; Abdel-Ghaffar KA; Iacono VJ
J Periodontal Res; 2016 Jun; 51(3):407-16. PubMed ID: 26549803
[TBL] [Abstract][Full Text] [Related]
8. Guided tissue regeneration for periodontal infra-bony defects.
Needleman IG; Worthington HV; Giedrys-Leeper E; Tucker RJ
Cochrane Database Syst Rev; 2006 Apr; (2):CD001724. PubMed ID: 16625546
[TBL] [Abstract][Full Text] [Related]
9. Impaired healing response of periodontal furcation defects following flap debridement surgery in smokers. A controlled clinical trial.
Trombelli L; Cho KS; Kim CK; Scapoli C; Scabbia A
J Clin Periodontol; 2003 Jan; 30(1):81-7. PubMed ID: 12702115
[TBL] [Abstract][Full Text] [Related]
10. Does enamel matrix derivative application provide additional clinical benefits in residual periodontal pockets associated with suprabony defects? A systematic review and meta-analysis of randomized clinical trials.
Graziani F; Gennai S; Cei S; Ducci F; Discepoli N; Carmignani A; Tonetti M
J Clin Periodontol; 2014 Apr; 41(4):377-86. PubMed ID: 24329867
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of a biphasic calcium composite grafting material in the treatment of human periodontal intrabony defects: a 12-month randomized controlled clinical trial.
Stein JM; Fickl S; Yekta SS; Hoischen U; Ocklenburg C; Smeets R
J Periodontol; 2009 Nov; 80(11):1774-82. PubMed ID: 19905932
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of a resorbable bone substitute with a resorbable membrane in the treatment of periodontal infrabony defect - A multicenter randomised controlled trial.
Esposito M; Grusovin MG; Lambert F; Matos S; Pietruska M; Rossi R; Salhi L; Buti J
Eur J Oral Implantol; 2015; 8(3):233-44. PubMed ID: 26355168
[TBL] [Abstract][Full Text] [Related]
13. Intrabony defects, open-flap debridement, and decortication: a randomized clinical trial.
Crea A; Deli G; Littarru C; Lajolo C; Orgeas GV; Tatakis DN
J Periodontol; 2014 Jan; 85(1):34-42. PubMed ID: 23537123
[TBL] [Abstract][Full Text] [Related]
14. Clinical and radiographic evaluation of regenerative potential of GTR membrane (Biomesh®) along with alloplastic bone graft (Biograft®) in the treatment of periodontal intrabony defects.
Mopur JM; Devi TR; Ali SM; Srinivasa TS; Gopinath V; Salam AR
J Contemp Dent Pract; 2013 May; 14(3):434-9. PubMed ID: 24171985
[TBL] [Abstract][Full Text] [Related]
15. Autogenous periosteal barrier membranes and bone grafts in the treatment of periodontal intrabony defects of single-rooted teeth: a 12-month reentry randomized controlled clinical trial.
Paolantonio M; Femminella B; Coppolino E; Sammartino G; D'Arcangelo C; Perfetti G; Perinetti G
J Periodontol; 2010 Nov; 81(11):1587-95. PubMed ID: 20583915
[TBL] [Abstract][Full Text] [Related]
16. Clinical and radiographic effects of ascorbic acid-augmented platelet-rich fibrin versus platelet-rich fibrin alone in intra-osseous defects of stage-III periodontitis patients: a randomized controlled clinical trial.
Elbehwashy MT; Hosny MM; Elfana A; Nawar A; Fawzy El-Sayed K
Clin Oral Investig; 2021 Nov; 25(11):6309-6319. PubMed ID: 33842996
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of hyaluronic acid in the treatment of periodontal intrabony defect: a systematic review and meta-analysis.
Ostos-Aguilar BI; Pinheiro Furquim C; Muniz FWMG; Faveri M; Meza-Mauricio J
Clin Oral Investig; 2023 May; 27(5):1923-1935. PubMed ID: 36598601
[TBL] [Abstract][Full Text] [Related]
18. Healing of intrabony defects following regenerative surgery by means of single-flap approach in conjunction with either hyaluronic acid or an enamel matrix derivative: a 24-month randomized controlled clinical trial.
Pilloni A; Rojas MA; Marini L; Russo P; Shirakata Y; Sculean A; Iacono R
Clin Oral Investig; 2021 Aug; 25(8):5095-5107. PubMed ID: 33565017
[TBL] [Abstract][Full Text] [Related]
19. Autologous platelet concentrates for treating periodontal infrabony defects.
Del Fabbro M; Karanxha L; Panda S; Bucchi C; Nadathur Doraiswamy J; Sankari M; Ramamoorthi S; Varghese S; Taschieri S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011423. PubMed ID: 30484284
[TBL] [Abstract][Full Text] [Related]
20. WITHDRAWN: Guided tissue regeneration for periodontal infra-bony defects.
Needleman I; Worthington HV; Giedrys-Leeper E; Tucker R
Cochrane Database Syst Rev; 2019 May; 5(5):CD001724. PubMed ID: 31141165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
